YTHDF2 and nonpapillary renal cell carcinoma: In summary, our results demonstrated that downregulation of YTHDF2 (a key m6A-related gene) is associated with poor prognosis of ccRCC patients, suggesting that YTHDF2 can serve as a prognostic biomarker of ccRCC.